Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Why would GEHA require a prior authorization for Wegovy
A more mindful, wellness-forward approach to GLP-1 use
For a deeper scientific exploration of these interconnected mechanisms, see our Akkermansia microbiome hub , where we break down how this keystone species supports gut lining stability, immune balance, and systemic metabolic signaling
Zepbound (tirzepatide) is used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obesity) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea, or cardiovascular disease)
Side effect profile Both formats produce similar GLP-1-related side effects because they deliver the same active molecule
Clinical trials have demonstrated that individuals using semaglutide for weight management can lose an average of 15% to 20% of their body weight over 68 weeks
